Tirzepatide's Effectiveness in HFpEF linked to Baseline BMI and Fat Distribution: SUMMIT Trial Dr Riya Dave5 Aug 2025 9:00 AM ISTA post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution significantly affect the...
Much Awaited Cardiac Safety Data of Tirzepatide Released Dr. Kamal Kant Kohli4 Aug 2025 8:15 AM ISTTopline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile comparable to dulaglutide...
Tirzepatide Matches dulaglutide in Heart Protection, Offers Added Benefits in SURPASS-CVOT trial Dr. Kamal Kant Kohli1 Aug 2025 9:15 AM ISTTopline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to dulaglutide in adults with...
Tirzepatide Outperforms Testosterone in Boosting Hormones and Body Composition in Obese Men: Pilot Study Medha Baranwal26 July 2025 9:00 AM ISTItaly: Tirzepatide (TZP), a dual receptor agonist for glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), may offer...
Tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide: Study Dr. Kamal Kant Kohli25 July 2025 9:15 AM ISTResearchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and...
Weight Returns for Many After Stopping Anti-Obesity Drugs: Meta-Analysis Dr. Bhumika Maikhuri23 July 2025 8:00 AM ISTPatients who take anti-obesity medications to aid in weight loss may experience significant weight regain after stopping the drugs, according to a new...
Tirzepatide May Lower LDL Cholesterol in Adults, Systematic Review Finds Medha Baranwal22 July 2025 9:15 AM ISTCosta Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of tirzepatide-a dual GIP...
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study Medha Baranwal19 July 2025 9:15 AM ISTTaiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss: Study Dr. Kamal Kant Kohli17 July 2025 9:15 AM ISTUsing tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity...
Medical Bulletin 15/Jul/2025 Dr. Bhumika Maikhuri15 July 2025 3:00 PM ISTHere are the top medical news for the day:Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and...
Taking This Obesity Medication with Menopause Hormone Therapy May Lead to More Effective Weight Loss: Study Suggests Dr. Bhumika Maikhuri15 July 2025 8:15 AM ISTPostmenopausal women with overweight or obesity experience significantly greater weight loss when treated with both tirzepatide and menopause hormone...
Tirzepatide Shakes Up Obesity Market as Mounjaro Records Rs 390 Mn Sales in June Farhat Nasim11 July 2025 3:05 PM ISTNew Delhi: In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly...
